يعرض 161 - 180 نتائج من 17,429 نتيجة بحث عن '(((( ((b large) OR (a large)) decrease ) OR ( i larvae increases ))) OR ( i largest decrease ))*', وقت الاستعلام: 1.71s تنقيح النتائج
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167

    Image_2_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg حسب Qikai Zhang (6905096)

    منشور في 2022
    "…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …"
  8. 168

    Image_1_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg حسب Qikai Zhang (6905096)

    منشور في 2022
    "…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …"
  9. 169

    Image_4_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg حسب Qikai Zhang (6905096)

    منشور في 2022
    "…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …"
  10. 170

    Image_3_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg حسب Qikai Zhang (6905096)

    منشور في 2022
    "…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …"
  11. 171

    Table1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.docx حسب Chaofeng Zhang (845343)

    منشور في 2024
    "…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …"
  12. 172

    Image1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG حسب Chaofeng Zhang (845343)

    منشور في 2024
    "…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …"
  13. 173

    Image2_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG حسب Chaofeng Zhang (845343)

    منشور في 2024
    "…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …"
  14. 174

    Supplementary Material for: STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma حسب Xiao S. (11834801)

    منشور في 2021
    "…However, the underlying mechanism of STAT3 in the pathogenesis of diffuse large B-cell lymphoma (DLBCL) has yet to be established. …"
  15. 175

    Image_4_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg حسب Zhouning Lin (14648597)

    منشور في 2023
    "…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …"
  16. 176

    Image_1_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg حسب Zhouning Lin (14648597)

    منشور في 2023
    "…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …"
  17. 177

    Image_5_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg حسب Zhouning Lin (14648597)

    منشور في 2023
    "…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …"
  18. 178

    Image_3_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg حسب Zhouning Lin (14648597)

    منشور في 2023
    "…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …"
  19. 179

    Image_2_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg حسب Zhouning Lin (14648597)

    منشور في 2023
    "…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …"
  20. 180